Celldex reports strong efficacy for urticaria drug regardless of IgE levels
PositiveFinancial Markets

Celldex has announced promising results for its new drug targeting urticaria, showing strong efficacy regardless of patients' IgE levels. This is significant as it suggests that the treatment could be effective for a broader range of patients, potentially transforming the management of this chronic condition. With urticaria affecting many individuals, these findings could lead to improved quality of life for those suffering from this often debilitating skin disorder.
— Curated by the World Pulse Now AI Editorial System